Scholars Central

CommentaryPublished 30 Nov 2020

ORF3a mutations: an adaptive advantage for SARS-CoV-2 pathogenecity

Authors: Sougata Niyogi, Parinita Majumdar

Journal of Cytokine Biology

Volume 5 · Issue 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The outbreak of severe acute respiratory syndrome in November 2019 resulted in a global public health emergency which warrants investigation of the virulence and pathogenecity of SARS-CoV-2. The reasonably higher mutation rate in SARS-CoV-2 led to the emergence of its numerous genetic variants which is likely to be responsible for COVID-19 associated morbidity and mortality. Mutations in ORF3a protein could modulate viral pathogenecity by interfering with host immune response and apoptotic pathways.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cytokine Biology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cytokine Biology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Sougata Niyogi”
  • BylineArticles whose byline prints “Parinita Majumdar”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels